{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:29Z","timestamp":1792643909572,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"SNSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.humpath.2026.106284","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:10:32Z","timestamp":1791990632000},"page":"106284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myeloid neoplasms with unusual patterns of disease evolution and progression other than acute leukemia: a European Bone Marrow Working Group workshop report"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4357-1570","authenticated-orcid":false,"given":"Leonie","family":"Saft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-3627","authenticated-orcid":false,"given":"Gorana","family":"Gasljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-293X","authenticated-orcid":false,"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106284_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000530940","article-title":"Progression in myeloid neoplasms: beyond the myeloblast","volume":"91","author":"Faria","year":"2024","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2026.106284_bib1","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.3324\/haematol.2019.227686","article-title":"Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a \"grey zone\" combination of myelodysplastic and myeloproliferative features?","volume":"105","author":"Sangiorgio","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106284_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41379-020-0624-y","article-title":"Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2\/MPL\/CALR) and SF3B1","volume":"34","author":"Ok","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/modpathol.2012.165","article-title":"Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease","volume":"26","author":"Boiocchi","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000548829","volume":"93","author":"Tzankov","year":"2026","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2026.106284_bib6","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.3390\/cancers13225605","article-title":"Molecular progression of myeloproliferative and myelodysplastic\/myeloproliferative neoplasms: a study on sequential bone marrow biopsies","volume":"13","author":"Brune","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106284_bib7","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/bloodadvances.2020002271","article-title":"Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation","volume":"4","author":"Luque Paz","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2026.106284_bib8","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2008-01-136366","article-title":"Activating mutations in human acute megakaryoblastic leukemia","volume":"112","author":"Malinge","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106284_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pathol.2021.08.015","article-title":"Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation","volume":"54","author":"Nagamine","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106284_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2018.11.022","article-title":"Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms","volume":"86","author":"Boiocchi","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib11","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1182\/bloodadvances.2020001528","article-title":"Outcome of patients with IDH1\/2-mutated post-myeloproliferative neoplasm AML in the era of IDH inhibitors","volume":"4","author":"Chifotides","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2026.106284_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ajh.26186","article-title":"Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: a multicenter series of 32 consecutive cases","volume":"96","author":"Gangat","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2026.106284_bib13","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/modpathol.2015.100","article-title":"Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications","volume":"28","author":"Boiocchi","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib14","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00277-024-05754-4","article-title":"Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis","volume":"103","author":"Chen","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2026.106284_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.prp.2014.10.004","article-title":"Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization","volume":"211","author":"Castelli","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2026.106284_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/bloodadvances.2016000216","article-title":"Targeted deep sequencing in polycythemia vera and essential thrombocythemia","volume":"1","author":"Tefferi","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2026.106284_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1329298","article-title":"Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination","volume":"13","author":"Zanelli","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2026.106284_bib18","first-page":"263","article-title":"Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia","volume":"104","author":"Maffei","year":"2025","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2026.106284_bib19","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106284_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.16380","article-title":"Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera","volume":"189","author":"Tefferi","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106284_bib21","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood.2019003347","article-title":"Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis","volume":"135","author":"Ronner","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106284_bib22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","article-title":"Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis","volume":"3","author":"Carobbio","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2026.106284_bib23","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.2023020232","article-title":"Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL","volume":"143","author":"Gerds","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106284_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/bjh.15010","article-title":"Screening for ASXL1 and SRSF2 mutations is imperative for treatment decision-making in otherwise low or intermediate-1 risk patients with myelofibrosis","volume":"183","author":"Tefferi","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106284_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ajh.24740","article-title":"Monocytosis in polycythemia vera: clinical and molecular correlates","volume":"92","author":"Barraco","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2026.106284_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11899-021-00660-2","article-title":"Myeloproliferative neoplasms with monocytosis","volume":"17","author":"Morsia","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.humpath.2026.106284_bib27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106284_bib28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106284_bib29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.15061","article-title":"Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis","volume":"183","author":"Tefferi","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106284_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bjh.15984","article-title":"The emergence of a JAK2 V617F-mutated clone in myelodysplastic syndrome is associated with disease progression and features of myelofibrosis","volume":"186","author":"Zhong","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106284_bib31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/modpathol.2017.45","article-title":"Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia","volume":"30","author":"Geyer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib32","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","article-title":"Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions","volume":"104","author":"Valent","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106284_bib33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.leukres.2006.12.025","article-title":"Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis","volume":"31","author":"Elliott","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2026.106284_bib34","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/leu.2013.97","article-title":"SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML","volume":"27","author":"Laborde","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106284_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171608","article-title":"Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: a meta-analysis","volume":"12","author":"Shou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2026.106284_bib36","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00432-017-2518-z","article-title":"Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies","volume":"143","author":"Winkelmann","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106284_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","article-title":"Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders","volume":"28","author":"Vermi","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00428-017-2075-5","article-title":"Sharing of a PTPN11 mutation by myelodysplastic bone marrow and a mature plasmacytoid dendritic cell proliferation provides evidence for their common myelomonocytic origin","volume":"470","author":"Bodmer","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106284_bib39","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","article-title":"Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia","volume":"33","author":"Lucas","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106284_bib40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/cup.13039","article-title":"Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: expanding the spectrum of skin lesions in chronic myelomonocytic leukemia","volume":"44","author":"Loghavi","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2017-01-761718","article-title":"High prevalence of myeloid neoplasms in adults with non- langerhans cell histiocytosis","volume":"130","author":"Papo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106284_bib42","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00277-018-3436-0","article-title":"Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th meeting of the european association for haematopathology (EAHP) organized by the european bone marrow working group, Basel 2016","volume":"97","author":"Tzankov","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2026.106284_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/cup.13918","article-title":"MAP2K1-driven mixed langerhans cell histiocytosis, rosai-dorfman-destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia","volume":"48","author":"Bonometti","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib44","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1111\/ajd.13491","article-title":"Cutaneous-group histiocytoses associated with myeloid malignancies: a systematic review of 102 cases","volume":"62","author":"Bonometti","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.humpath.2026.106284_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00277-020-04307-9","article-title":"Progression, transformation and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV european bone marrow working group course 2019","volume":"100","author":"Hebeda","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2026.106284_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cjp2.177","article-title":"Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation","volume":"7","author":"Kemps","year":"2021","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.humpath.2026.106284_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19095","article-title":"Indeterminate cell histiocytosis: a systematic review of the literature with a comprehensive revision of clinical, histopathological, and molecular features","author":"Zanella","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.humpath.2026.106284_bib48","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1182\/bloodadvances.2024013545","article-title":"Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms","volume":"8","author":"Ozkaya","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2026.106284_bib49","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00428-025-04114-5","article-title":"Plasmacytoid dendritic cell proliferations, malignant histiocytic (macrophage\/dendritic cell) neoplasms and follicular dendritic cell neoplasms: report from the 2024 joint CSHP\/EA4HP\/SH workshop","volume":"487","author":"Egan","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106284_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-025-04096-4","article-title":"Histiocytoses and reactive proliferations of histiocytes: current state of the art and evolving concepts-a report from the joint CSHP-EA4HP-SH workshop 2024, Hefei, China","volume":"488","author":"Fend","year":"2026","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106284_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/blood-2016-12-757377","article-title":"Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem\/progenitor cells","volume":"130","author":"Durham","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106284_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood.2020005101","article-title":"High frequency of clonal hematopoiesis in Erdheim-Chester disease","volume":"137","author":"Cohen Aubart","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106284_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100352","article-title":"Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features but share ancestral clonal mutations with bone marrow","volume":"37","author":"Sadigh","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib54","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/modpathol.2017.182","article-title":"Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group","volume":"31","author":"Soderquist","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106284_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/bjh.13932","article-title":"BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance","volume":"176","author":"Martin-Cabrera","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106284_bib56","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.3390\/cancers15245888","article-title":"Clinical, histopathological and molecular spectrum of cutaneous lesions in myelodysplastic syndrome and myeloproliferative neoplasms (MDS\/MPN): an integrative review","volume":"15","author":"Prieto-Torres","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106284_bib57","article-title":"Indeterminate dendritic cell tumor with persistent complete metabolic response to BRAF\/MEK inhibition","volume":"5","author":"Thurner","year":"2020","journal-title":"HemaSphere"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:46:14Z","timestamp":1792640774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726002534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S0046817726002534"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106284","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid neoplasms with unusual patterns of disease evolution and progression other than acute leukemia: a European Bone Marrow Working Group workshop report","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106284"}}